Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7074331 | 0.88 | TSHR (0.45) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL19456974 | 0.88 | TSHR (0.45) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL6557557 | 0.88 | TSHR (0.45) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL672062 | 0.86 | TSHR (0.50) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL23494200 | 0.85 | TSHR (0.47) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL28163015 | 0.85 | TSHR (0.42) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL27759351 | 0.85 | TSHR (0.42) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL185499 | 0.85 | TSHR (0.53) | TSHRHPGDFAAHALDH1A1CYP3A4 | |
| SCHEMBL991328 | 0.83 | FAAH (0.50) | TSHRHPGDFAAHALDH1A1CNR1 | |
| SCHEMBL28597918 | 0.83 | TSHR (0.46) | TSHRHPGDFAAHALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116515023-A | Composition and cured product | 东京应化工业株式会社 | 2023-08-01 | — | — | CN | disclosed |
| CN-116514161-A | Nanoparticle, nanoparticle dispersion liquid, and method for producing nanoparticle | 东京应化工业株式会社 | 2023-08-01 | — | — | CN | disclosed |
| CN-116041382-A | Method for producing organosilicon compounds containing (meth) acryloxy groups | 信越化学工业株式会社 | 2023-05-02 | — | — | CN | disclosed |
| US-20030064172-A1 | Liquid-crystalline medium | MERCK PATENT GESELLSCHAFT MITBESCHRANKTER HAFTUNG (DE) | 2003-04-03 | — | — | US | disclosed |
| US-5643495-A | 1,2,2,2-tetrafluoroethyl ethers, and liquid-crystalline medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1997-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064172-A1 | Liquid-crystalline medium | AQP1, ZYX, ROCK1 | TSHR 4445/4885HPGD 4516/4885FAAH 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.